1-2-(2,4 dimethylphenylsulfanyl)-phenylpiperazine as a compound with combined serotonin reuptake, 5-HT₃ and 5-HT_1A activity for the treatment of cognitive impairment

摘要

This disclosure relates to a method of treating a disease selected from the group consisting of Alzheimer's disease, cognitive impairment, and attention deficit hyperactivity disorder (ADHD). The method includes administering a therapeutically effective amount of Compound I or a pharmaceutically acceptable salt thereof to patient in need thereof, in which Compound I is 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine.